AU2002214477A1 - Modified nucleosides and nucleotides and use thereof - Google Patents

Modified nucleosides and nucleotides and use thereof

Info

Publication number
AU2002214477A1
AU2002214477A1 AU2002214477A AU1447702A AU2002214477A1 AU 2002214477 A1 AU2002214477 A1 AU 2002214477A1 AU 2002214477 A AU2002214477 A AU 2002214477A AU 1447702 A AU1447702 A AU 1447702A AU 2002214477 A1 AU2002214477 A1 AU 2002214477A1
Authority
AU
Australia
Prior art keywords
nucleotides
modified nucleosides
nucleosides
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002214477A
Inventor
Jyoti Chattopadhyaya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002214477A1 publication Critical patent/AU2002214477A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/323—Chemical structure of the sugar modified ring structure
    • C12N2310/3231—Chemical structure of the sugar modified ring structure having an additional ring, e.g. LNA, ENA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002214477A 2000-11-09 2001-11-09 Modified nucleosides and nucleotides and use thereof Abandoned AU2002214477A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24739900P 2000-11-09 2000-11-09
US60247399 2000-11-09
US30806301P 2001-07-25 2001-07-25
US60308063 2001-07-25
PCT/SE2001/002484 WO2002038578A1 (en) 2000-11-09 2001-11-09 Modified nucleosides and nucleotides and use thereof

Publications (1)

Publication Number Publication Date
AU2002214477A1 true AU2002214477A1 (en) 2002-05-21

Family

ID=26938657

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002214477A Abandoned AU2002214477A1 (en) 2000-11-09 2001-11-09 Modified nucleosides and nucleotides and use thereof

Country Status (4)

Country Link
US (1) US20040142946A1 (en)
EP (1) EP1332150A1 (en)
AU (1) AU2002214477A1 (en)
WO (1) WO2002038578A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US9096636B2 (en) 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US7087589B2 (en) * 2000-01-14 2006-08-08 The United States Of America As Represented By The Department Of Health And Human Services Methanocarba cycloakyl nucleoside analogues
EP2957568B1 (en) * 2002-11-05 2016-12-21 Ionis Pharmaceuticals, Inc. Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
EP1644475A4 (en) 2003-06-20 2009-06-03 Isis Pharmaceuticals Inc Double stranded compositions comprising a 3'-endo modified strand for use in gene modulation
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
US8415315B2 (en) 2004-05-06 2013-04-09 University Of Central Florida Research Foundation, Inc. Methods and compositions for inhibiting the proliferation of cancer cells
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
JP5723154B2 (en) 2007-09-19 2015-05-27 アプライド バイオシステムズ リミテッド ライアビリティー カンパニー SiRNA sequence-independent modification format for reducing the influence of off-target phenotype in RNAi and its stabilized form
AU2008338530A1 (en) 2007-12-14 2009-06-25 Minitube Of America, Inc. Gender-specific separation of sperm cells and embryos
WO2011032034A2 (en) 2009-09-10 2011-03-17 University Of Idaho Nucleobase-functionalized conformationally restricted nucleotides and oligonucleotides for targeting nucleic acids
US8518957B2 (en) 2009-12-02 2013-08-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing intraocular pressure
BR112014001075A2 (en) 2011-07-19 2016-11-29 Univ Idaho probe, its use, in vitro method for associating a probe with a target and kit

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125567A (en) * 1964-03-17 G-amino-z-d-psicofuranosylpurine deriva-
US3126372A (en) * 1964-03-24 Z-d-psicofuranosylpurine derivatives
US3020274A (en) * 1958-03-10 1962-02-06 Upjohn Co 6-amino-9-d-psicofuranosylpurine
US3079378A (en) * 1960-02-01 1963-02-26 Upjohn Co Acylated psicofuranosyladenines

Also Published As

Publication number Publication date
US20040142946A1 (en) 2004-07-22
WO2002038578A1 (en) 2002-05-16
EP1332150A1 (en) 2003-08-06

Similar Documents

Publication Publication Date Title
AU2001282522A1 (en) Novel nucleoside analogs and oligonucleotide derivatives containing these analogs
EP1287154A4 (en) Charge-switch nucleotides
IL141034A0 (en) Uracil compounds and use thereof
HUP0105367A3 (en) Novel nucleosides and oligonucleotide analogues
EP1247815A3 (en) Modified oligonucleotides and uses thereof
AU2001278061A1 (en) Triphosphate oligonucleotide modification reagents and uses thereof
AU2002329759A1 (en) Methyltransferase genes and uses thereof
AU2002214477A1 (en) Modified nucleosides and nucleotides and use thereof
AU2002211717A1 (en) Stresscopins and their uses
EP1544294B8 (en) Nucleosides or nucleotides having novel unnatural bases and use thereof
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001248817A1 (en) Form panel and panel holding member
AU2002213429A1 (en) Antiviral methods and compounds
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001293048A1 (en) Antiviral compositions and methods of use
AU2001240098A1 (en) 4'-thio-l-xylo furanosyl nucleosides, precursors thereof, preparation and use thereof
AU2001284902A1 (en) Human adenosine deaminase
AU5569200A (en) Uracil compounds and use thereof
AU4432001A (en) Trityl-type compounds and their use
AU2001285257A1 (en) Human telomerase rna elements
AU2002223446A1 (en) Multifunctional and multiparametric biochip arrangement
AU2002224825A1 (en) Substituted amidoalkyl uracils and the use thereof
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2001284485A1 (en) Adenosine derivatives and use thereof